ProtodeltoninCAS# 94992-08-2 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 94992-08-2 | SDF | Download SDF |
PubChem ID | 441885 | Appearance | Powder |
Formula | C51H84O23 | M.Wt | 1065.21 |
Type of Compound | Steroids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-2-[[(1S,2S,4S,6R,7S,8R,9S,12S,13R,16S)-6-hydroxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-16-yl]oxy]-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol | ||
SMILES | CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)CO)O)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)OC1(CCC(C)COC9C(C(C(C(O9)CO)O)O)O)O | ||
Standard InChIKey | RPYHJEFMMXMMHG-AATSBFCISA-N | ||
Standard InChI | InChI=1S/C51H84O23/c1-20(19-66-45-39(61)37(59)34(56)29(16-52)69-45)8-13-51(65)21(2)32-28(74-51)15-27-25-7-6-23-14-24(9-11-49(23,4)26(25)10-12-50(27,32)5)68-48-44(73-46-40(62)36(58)33(55)22(3)67-46)42(64)43(31(18-54)71-48)72-47-41(63)38(60)35(57)30(17-53)70-47/h6,20-22,24-48,52-65H,7-19H2,1-5H3/t20-,21+,22+,24+,25-,26+,27+,28+,29-,30-,31-,32+,33+,34-,35-,36-,37+,38+,39-,40-,41-,42+,43-,44-,45-,46+,47+,48-,49+,50+,51-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Protodeltonin can inhibit the proliferation of a panel of established human and murine cancer cell lines in vitro. 2. Protodeltonin may have anti-thrombotic activity by both improving the anticoagulation activity and inhibiting platelet aggregation action. |
Targets | Bcl-2/Bax | Caspase | PARP |
Protodeltonin Dilution Calculator
Protodeltonin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 0.9388 mL | 4.6939 mL | 9.3878 mL | 18.7756 mL | 23.4696 mL |
5 mM | 0.1878 mL | 0.9388 mL | 1.8776 mL | 3.7551 mL | 4.6939 mL |
10 mM | 0.0939 mL | 0.4694 mL | 0.9388 mL | 1.8776 mL | 2.347 mL |
50 mM | 0.0188 mL | 0.0939 mL | 0.1878 mL | 0.3755 mL | 0.4694 mL |
100 mM | 0.0094 mL | 0.0469 mL | 0.0939 mL | 0.1878 mL | 0.2347 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Gambogellic acid
Catalog No.:BCN8609
CAS No.:173867-04-4
- Cnidicin
Catalog No.:BCN8608
CAS No.:14348-21-1
- Lucidenic acid B
Catalog No.:BCN8607
CAS No.:95311-95-8
- Toringin
Catalog No.:BCN8606
CAS No.:1329-10-8
- Saikosaponin I
Catalog No.:BCN8605
CAS No.:103629-71-6
- Uvarigranol C
Catalog No.:BCN8604
CAS No.:172104-04-0
- 9-Methymyrrhone
Catalog No.:BCN8603
CAS No.:1809980-22-0
- Asperosaponin IV
Catalog No.:BCN8602
CAS No.:126778-93-6
- Rubipodanone A
Catalog No.:BCN8601
CAS No.:2170211-22-8
- Astraganoside
Catalog No.:BCN8600
CAS No.:1011711-05-9
- Isoastragaloside IV
Catalog No.:BCN8599
CAS No.:136033-55-1
- Eriosematin
Catalog No.:BCN8598
CAS No.:168010-17-1
- Licoarylcoumarin
Catalog No.:BCN8612
CAS No.:125709-31-1
- Pratensein 7-O-glucopyranoside
Catalog No.:BCN8613
CAS No.:36191-03-4
- Plantainoside D
Catalog No.:BCN8614
CAS No.:147331-98-4
- Suspenoidside B
Catalog No.:BCN8615
CAS No.:2161432-08-0
- 7beta-Hydroxybufalin
Catalog No.:BCN8616
CAS No.:20143-97-9
- 6'-O-Cinnamoylharpagide
Catalog No.:BCN8617
CAS No.:1245572-24-0
- 3,4,4a,9,10,10a-heexahydro-8-hydroxy-1-(hydroxymethyl)-1,4a-dimethyl-7-(1-methylethyl)-phenanthrene-2(1H)-one
Catalog No.:BCN8618
CAS No.:262599-12-2
- Sargentol
Catalog No.:BCN8619
CAS No.:623928-18-7
- Onjisaponin Z
Catalog No.:BCN8620
CAS No.:1078708-72-1
- Periplocoside M
Catalog No.:BCN8621
CAS No.:116782-73-1
- Sibirioside A
Catalog No.:BCN8622
CAS No.:173046-19-0
- Laetanine
Catalog No.:BCN8623
CAS No.:72361-67-2
Cytotoxicity and apoptosis-inducing effect of steroidal saponins from Dioscorea zingiberensis Wright against cancer cells.[Pubmed:22575181]
Steroids. 2012 Oct;77(12):1219-27.
Steroidal saponins from Dioscorea zingiberensis Wright (DZW) have shown cytotoxic activity in cancer cells. In this study, we isolated and identified seven steroidal saponins from the rhizomes of DZW: diosgenin, trillin, diosgenin diglucoside, deltonin, zingiberensis saponin (ZS), Protodeltonin and parvifloside. Our results showed that these seven compounds inhibited the proliferation of a panel of established human and murine cancer cell lines in vitro. ZS had more cytotoxic effect than the other saponins, even close to doxorubicin on the murine colon carcinoma cell line C26. The proliferation inhibitory effect of ZS was associated with its apoptosis-inducing effect by activation of caspase-3 and caspase-9 and specific proteolytic cleavage of poly (ADP-ribose) polymerase. Exposure of C26 to ZS also resulted in Bax upregulation and Bcl-2 downregulation. In conclusion, the findings of this study demonstrated that ZS is an effective natural agent for cancer therapy, which may be mediated, in part, by induction of apoptosis, and DZW's potential as an anticancer agent is worth being further investigated.
Anti-thrombotic activity and chemical characterization of steroidal saponins from Dioscorea zingiberensis C.H. Wright.[Pubmed:20659537]
Fitoterapia. 2010 Dec;81(8):1147-56.
Steroidal saponins have long attracted scientific attention, due to their structural diversity and significant biological activities. Total steroidal saponins (TSS) extracted from the rhizomes of Dioscorea zingiberensis C.H. Wright (DZW) constitute an effective treatment for cardiovascular disease. However, the active constituents contained in DZW rhizomes and their pharmacological properties are not fully understood. The aim of this work is to determine and quantify the active constituents in DZW rhizomes using fingerprint technique, and evaluate its anti-thrombotic activity using inferior vena cava ligation thrombosis rat model and pulmonary thrombosis mice model after being gavaged with TSS for 1 or 2weeks. In the study, a chemical fingerprint method was firstly established and validated to quantify and standardize TSS from DZW rhizomes including parvifloside, Protodeltonin, protodioscin, protogracillin, zingiberensis saponin, deltonin, dioscin and trillin. TSS extracted from DZW rhizomes were showed to have the inhibitions on platelet aggregation (PAG) and thrombosis, and prolong activated partial thromboplastin time (APTT), thrombin time (TT), and prothrombin time (PT) in a dose-dependent manner in rats. TSS also prolonged the bleeding time and clotting time in a dose-dependent manner in mice. The results indicate that TSS could inhibit thrombosis by both improving the anticoagulation activity and inhibiting PAG action, suggesting that TSS from DZW rhizomes have the potential to reduce the risk of cardiovascular diseases by anti-thrombotic action.